Dr. Reddy's Laboratories Limited (RDDA) — Free Cash Flow Generation Index
Dr. Reddy's Laboratories Limited (RDDA) has a Free Cash Flow Generation Index of 0.33x as of December 2025. Free cash flow of €3.59 Billion represents 0% of operating cash flow (€10.91 Billion). See Dr. Reddy's Laboratories Limited (RDDA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Dr. Reddy's Laboratories Limited across 9 annual periods. Explore RDDA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Free Cash Flow Generation Index for Dr. Reddy's Laboratories Limited. For the full company profile including market capitalisation, see market cap of Dr. Reddy's Laboratories Limited.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | €12.03 Billion | €46.43 Billion | €34.40 Billion | ▼ -34.6% |
| 2024 | 0.40x | €18.00 Billion | €45.43 Billion | €27.43 Billion | ▼ -41.7% |
| 2023 | 0.68x | €40.01 Billion | €58.88 Billion | €18.87 Billion | ▲ +110.9% |
| 2022 | 0.32x | €9.06 Billion | €28.11 Billion | €14.66 Billion | ▼ -50.3% |
| 2021 | 0.65x | €23.14 Billion | €35.70 Billion | €9.74 Billion | ▼ -18.5% |
| 2020 | 0.80x | €23.73 Billion | €29.84 Billion | €4.85 Billion | ▲ +7.6% |
| 2019 | 0.74x | €21.21 Billion | €28.70 Billion | €6.96 Billion | ▲ +90.7% |
| 2018 | 0.39x | €6.99 Billion | €18.03 Billion | €9.29 Billion | ▼ -75.3% |
| 2017 | 1.57x | €33.79 Billion | €21.51 Billion | €12.28 Billion | — |